Bone-targeting particles improved bone structure in mice

An experiment in mice whose ovaries had been removed found that engineered, bone-targeting particles also reduced pain-related behaviours.

ACS Biomaterials Science & Engineering

In an animal experiment, mice whose ovaries had been removed received engineered particles designed to target bone. These were exosomes, small packages released by cells. Researchers collected them from Schwann cells, which support nerves, after exposing those cells to nerve growth factor, a protein that supports nerve growth.

The particles improved microscopic bone structure in the mice. They increased the activity of bone-building cells and reduced the activity of cells that break down bone. They also reduced pain-related behaviours. In bone marrow mesenchymal stem cells—cells that can develop into bone-forming cells—grown in the lab, the particles promoted bone-forming development and mineral deposition.

Why it matters

Osteoporosis involves fragile bones and chronic pain. The work addressed whether nerve growth factor’s regenerative properties could be used while limiting its pain-inducing side effects.

Caveats

The pain outcome was measured through behaviour in mice, not people’s reports of pain. These animal and lab-cell experiments do not establish safety or benefit in people with osteoporosis.

The paper

Targeted Delivery of NGF-Pretreated Schwann Cell-Derived Exosomes for Osteoporosis Therapy: Overcoming Pain while Enhancing Bone Formation

Shanxi Medical University

ACS Biomaterials Science & Engineering · 28 Sep 2026

doi.org/10.1021/acsbiomaterials.6c00906PubMed 42804351